Lifecore Biomedical (LFCR) Reports Q1 Loss of $0.53/sh

Lifecore Biomedical (NASDAQ: LFCR) reported Q1 EPS of ($0.53), versus ($0.35) reported last year. Revenue for the quarter came in at $24.7 million, versus $24.5 million reported last year.

GUIDANCE:

Lifecore Biomedical sees FY2025 revenue of $126.5-130 million.

For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• enVVeno Medical (NVNO) files $100M mixed shelf
• Sigma Lithium resumes full operations after signing TAC agreement